| 英文别名 |
ATR inhibitor 1;BDBM412025;BCP23596;2-amino-6-fluoro-N-(5-fluoro-4-(1-methyl-1H-imidazol-5-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide;2-Amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;2-amino-6-fluoro-N-[5-fluoro-4-(3-methylimidazol-4-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;Tuvusertib;M1774;ATR Kinase Inhibitor M1774;NSC843572;SCHEMBL15770377;RBQPCTBFIPVIJN-UHFFFAOYSA-N;NSC-839425;ATR inhibitor 1?;GTPL12082;CHEMBL5314933;M1774; ATR inhibitor 1;US10392391, Compound I-C-79;M 1774;compound I-C-79 (WO2014089379A1);DB-134636;tuvusertib [INN];JE1BE6ZGZ7;D12882;Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 2-amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)-3-pyridinyl]-;NSC839425;M 1774 [WHO-DD];Tuvusertib (USAN/INN);HY-111451;AKOS040732492;MS-25948;1613200-51-3;G16749;EX-A3718;VX-400;CS-0040925;2-amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;M-1774;TUVUSERTIB [USAN];NSC-843572;compound I-C-79 [WO2014089379A1] |
扫码关注公众号
